Claudia Thiel-Giesecke
Berlin, BE 14195, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
CD8+ T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells.
Journal: Science advances
Published: May 21, 2025
Aging and Viral Evolution Impair Immunity Against Dominant Pan-Coronavirus-Reactive T Cell Epitope.
Journal: European journal of immunology
Published: February 17, 2025
The dorsal aortic compartment is a developmental source of brown adipose tissue in mice.
Journal: Nature communications
Published: November 27, 2024
Mesenchymal Osr1+ cells regulate embryonic lymphatic vessel formation.
Journal: Development (Cambridge, England)
Published: January 31, 2024
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity.
Journal: Frontiers in immunology
Published: September 28, 2022
SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity.
Journal: Kidney international
Published: July 28, 2022
Odd skipped-related 1 controls the pro-regenerative response of fibro-adipogenic progenitors.
Journal: NPJ Regenerative medicine
Published: May 30, 2022
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 07, 2022
Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 28, 2021
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
Journal: Science (New York, N.Y.)
Published: September 01, 2021
Last Updated: 09/26/2026